2. Personality/Psychosocial/
Psychiatric/Psychological Evaluation
a. These
are generally accepted and well-established and widely used diagnostic
procedures not only with selected use in acute pain problems, but have also
with more widespread use in subacute and chronic pain populations.
i. Diagnostic evaluations should distinguish
between conditions that are pre-existing, aggravated by the current injury, or
work related.
ii. interpersonal
relationships-both social and work;
iii. patient activities;
iv. current perception of the medical
system;
v. current
perception/attitudes toward employer/job;
vi. results of current treatment;
vii. risk factors and psychological
comorbidities that may influence outcome and that may require
treatment;
viii. childhood history,
including history of childhood psychological trauma, abuse and family history
of disability.
b.
Psychosocial evaluations should determine if further psychosocial or behavioral
interventions are indicated for patients diagnosed with chronic pain. The
interpretations of the evaluation should provide clinicians with a better
understanding of the patient in his or her social environment, thus allowing
for more effective rehabilitation. Psychosocial assessment requires
consideration of variations in pain experience and expression resulting from
affective, cognitive, motivational and coping processes, and other influences
such as gender, age, race, ethnicity, national origin, religion, sexual
orientation, disability, language, or socioeconomic status.
i. Frequency: one-time visit for the clinical
interview. If psychometric testing is indicated as a part of the initial
evaluation, time for such testing should not exceed an additional two hours of
professional time.
(a). Clinical Evaluation:
All chronic pain patients should have a clinical evaluation that addresses the
following areas:
(i). History of Injury - The
history of the injury should be reported in the patient's words or using
similar terminology. Caution must be exercised when using translators.
[a]. nature of injury;
[b]. psychosocial circumstances of the
injury;
[c]. current symptomatic
complaints;
[d]. extent of medical
corroboration;
[e]. treatment
received and results;
[f].
compliance with treatment;
[g].
coping strategies used, including perceived locus of control;
[h]. perception of medical system and
employer;
[i]. history of response
to prescription medications.
(ii). Health History
[a]. nature of injury;
[b]. medical history;
[c]. psychiatric history;
[d]. history of alcohol or substance
abuse;
[e]. activities of daily
living;
[f]. mental status
exam;
[g]. previous injuries,
including disability, impairment, and compensation
(iii). Psychosocial History
[a]. childhood history, including
abuse;
[b]. educational
history;
[c]. family history,
including disability;
[d]. marital
history and other significant adulthood activities and events;
[e]. legal history, including criminal and
civil litigation;
[f]. employment
and military history;
[g]. signs of
pre-injury psychological dysfunction;
[h]. current interpersonal relations,
support, living situation;
[i].
financial history.
(iv).
Psychological test results, if performed
(v). Danger to self or others.
(vi). Current psychiatric diagnosis
consistent with the standards of the American Psychiatric Association's
Diagnostic and Statistical Manual of Mental Disorders.
(vii). Pre-existing psychiatric conditions.
Treatment of these conditions is appropriate when the pre-existing condition
affects recovery from chronic pain.
(viii). Causality (to address medically
probable cause and effect, distinguishing pre-existing psychological symptoms,
traits and vulnerabilities from current symptoms).
(ix). Treatment recommendations with respect
to specific goals, frequency, timeframes, and expected
outcomes.
(b). Tests of
Psychological Functioning: Psychometric Testing is a valuable component of a
consultation to assist the physician in making a more effective treatment plan.
Psychometric testing is useful in the assessment of mental conditions, pain
conditions, cognitive functioning, treatment planning, vocational planning, and
evaluation of treatment effectiveness. There is no general agreement as to
which standardized psychometric tests should be specifically recommended for
psychological evaluations of chronic pain conditions. It is appropriate for the
mental health provider to use their discretion and administer selective
psychometric tests within their expertise and within standards of care in the
community. Some of these tests are available in Spanish and other languages,
and many are written at a sixth grade reading level. Examples of frequently
used psychometric tests performed include, but not limited to, the following.
(i). Comprehensive Inventories for Medical
Patients
[a]. Battery for Health Improvement,
2nd Edition (BHI-2). What it measures Depression, anxiety and hostility;
violent and suicidal ideation; borderline, dependency, chronic maladjustment,
substance abuse, conflicts with work, family and physician, pain preoccupation,
somatization, perception of functioning and others. Benefits When used as a
part of a comprehensive evaluation, can contribute substantially to the
understanding of psychosocial factors underlying pain reports, perceived
disability, somatic preoccupation, and help to design interventions. Serial
administrations can track changes in a broad range of variables during the
course of treatment, and assess outcome.
[b]. Millon Behavioral Medical Diagnostic
(MBMD). What it Measures Updated version of the Millon Behavioral Health
Inventory (MBHI). Provides information on Coping Styles (introversive,
inhibited, dejected, cooperative, sociable, etc), Health Habits (smoking,
drinking, eating, etc.), Psychiatric Indications (anxiety, depression, etc),
stress moderators (Illness Apprehension vs. Illness Tolerance, etc), treatment
prognostics (Interventional Fragility vs. Interventional Resilience, Medication
Abuse vs. Medication Competence, etc) and other factors. Benefits When used as
a part of a comprehensive evaluation, can contribute substantially to the
understanding of psychosocial factors affecting medical patients. Understanding
risk factors and patient personality type can help to optimize treatment
protocols for a particular patient.
[c]. Pain Assessment Battery (PAB). What it
measures - collection of four separate measures that are administered together.
Emphasis on the assessment of pain, coping strategies, degree and frequency of
distress, health-related behaviors, coping success, beliefs about pain, quality
of pain experience, stress symptoms analysis, and others. Benefits-When used as
a part of a comprehensive evaluation, can contribute substantially to the
understanding of patient stress, pain reports and pain coping strategies, and
help to design interventions. Serial administrations can track changes in
measured variables during the course of treatment, and assess
outcome.
ii. Comprehensive Psychological Inventories.
These tests are designed for detecting various psychiatric syndromes, but in
general are more prone to false positive findings when administered to medical
patients.
(a). Millon Clinical Multiaxial
Inventory, 3rd Edition (MCMI-III). What it measures - has scales based on DSM
diagnostic criteria for affective, personality, and psychotic disorders and
somatization. Benefits - when used as a part of a part of a comprehensive
evaluation, can screen for a broad range of DSM diagnoses.
(b). Minnesota Multiphasic Personality
Inventory, 2nd Edition (MMPI-2). What it measures - original scale constructs,
such as hysteria and psychesthenia are archaic but continue to be useful. Newer
content scales include depression, anxiety, health concerns, bizarre mentation,
social discomfort, low self-esteem, and almost 100 others. Benefits When used
as a part of a comprehensive evaluation, measure a number of factors that have
been associated with poor treatment outcome.
(c). Personality Assessment Inventory (PAI).
What it measures - a good measure of general psychopathology. Measures
depression, anxiety, somatic complaints, stress, alcohol and drug use reports,
mania, paranoia, schizophrenia, borderline, antisocial, and suicidal ideation
and more than 30 others. Benefits When used as a part of a comprehensive
evaluation, can contribute substantially to the identification of a wide
variety of risk factors that could potentially affect the medical
patient.
iii. Brief
Multidimensional Screens for Medical Patients. Treating providers, to assess a
variety of psychological and medical conditions, including depression, pain,
disability and others, may use brief instruments. These instruments may also be
employed as repeated measures to track progress in treatment, or as one test in
a more comprehensive evaluation. Brief instruments are valuable in that the
test may be administered in the office setting and hand scored by the
physician. Results of these tests should help providers distinguish which
patients should be referred for a specific type of comprehensive evaluation.
(a). Brief Battery for Health Improvement,
2nd Edition (BBHI-2). What it measures Depression, anxiety, somatization, pain,
function, and defensiveness. Benefits Can identify patients needing treatment
for depression and anxiety, and identify patients prone to somatization, pain
magnification and self-perception of disability. Can compare the level of
factors above to other pain patients and community members. Serial
administrations can track changes in measured variables during the course of
treatment, and assess outcome.
(b).
Multidimensional Pain Inventory (MPI). What it measures - interference,
support, pain severity, life-control, affective distress, response of
significant other to pain, and self-perception of disability at home and work,
and in social and other activities of daily living. Benefits Can identify
patients with high levels of disability perceptions, affective distress, or
those prone to pain magnification. Serial administrations can track changes in
measured variables during the course of treatment, and assess
outcome.
(c). Pain Patient Profile
(P3). What it measures Assesses depression, anxiety, and somatization. Benefits
Can identify patients needing treatment for depression and anxiety, as well as
identify patients prone to somatization. Can compare the level of depression,
anxiety and somatization to other pain patients and community members. Serial
administrations can track changes in measured variables during the course of
treatment, and assess outcome.
(d).
SF-36 a. What it measures - a survey of general health well-being and
functional states. Benefits - assesses a broad spectrum of patient disability
reports. Serial administrations could be used to track patient perceived
functional changes during the course of treatment, and assess
outcome.
(e). Sickness Impact
Profile (SIP). What it measures - perceived disability in the areas of sleep,
eating, home management, recreation, mobility, body care, social interaction,
emotional behavior, and communication. Benefits - assesses a broad spectrum of
patient disability reports. Serial administrations could be used to track
patient perceived functional changes during the course of treatment, and assess
outcome.
(f). McGill Pain
Questionnaire (MPQ). What it measures - cognitive, emotional and sensory
aspects of pain. Benefits - can identify patients prone to pain magnification.
Repeated administrations can track progress in treatment for pain.
(g). McGill Pain Questionnaire - Short Form
(MPQ-SF). What it measures - emotional and sensory aspects of pain. Benefits -
can identify patients prone to pain magnification. Repeated administrations can
track progress in treatment for pain.
(h). Oswestry Disability Questionnaire. What
it measures - disability secondary to low back pain. Benefits - can measure
patients' self-perceptions of disability. Serial administrations could be used
to track changes in self-perceptions of functional ability during the course of
treatment, and assess outcome.
(i).
Visual Analog Scales (VAS). What it measures - graphical measure of patient's
pain report. Benefits - quantifies the patients' pain report. Serial
administrations could be used to track changes in pain reports during the
course of treatment and assess outcome.
iv. Brief Multidimensional Screens for
Psychiatric Patients. These tests are designed for detecting various
psychiatric syndromes, but in general are more prone to false positive findings
when administered to medical patients.
(a).
Brief Symptom Inventory. What it measures: Somatization, obsessive-compulsive,
depression, anxiety, phobic anxiety, hostility, paranoia, psychoticism, and
interpersonal sensitivity. Benefits: Can identify patients needing treatment
for depression and anxiety, as well as identify patients prone to somatization.
Can compare the level of depression, anxiety, and somatization to community
members. Serial administrations could be used to track changes in measured
variables during the course of treatment, and assess outcome.
(b). Brief Symptom Inventory - 18 (BSI-18).
What it Measures: Depression, anxiety, somatization. Benefits: Can identify
patients needing treatment for depression and anxiety, as well as identify
patients prone to somatization. Can compare the level of depression, anxiety,
and somatization to community members. Serial administrations could be used to
track patient perceived functional changes during the course of treatment, and
assess outcome.
(c). Symptom Check
List 90 (SCL 90). What it measures: Somatization, obsessive-compulsive,
depression, anxiety, phobic anxiety, hostility, paranoia, psychoticism, and
interpersonal sensitivity. Benefits: Can identify patients needing treatment
for depression and anxiety, as well as identify patients prone to somatization.
Can compare the level of depression, anxiety and somatization to community
members. Serial administrations could be used to track changes in measured
variables during the course of treatment, and assess outcome.
v. Brief Specialized Psychiatric
Screening Measures
(a). Beck Depression
Inventory (BDI). What it measures: Depression. Benefits: Can identify patients
needing referral for further assessment and treatment for depression and
anxiety, as well as identify patients prone to somatization. Repeated
administrations can track progress in treatment for depression, anxiety, and
somatic preoccupation.
(b). Post
Traumatic Stress Diagnostic Scale (PDS). What it Measures: Post Traumatic
Stress Disorder (PTSD). Benefits: Helps confirm suspected PTSD diagnosis.
Repeated administrations can track treatment progress of PTSD
patients.
(c). Center of
Epidemiologic Studies - Depression Questionnaire. What it measures: Depression.
Benefits: Brief self-administered screening test. Requires professional
evaluation to verify diagnosis.
(d). Brief Patient Health Questionnaire from
PRIME - MD. What it measures: Depression, panic disorder. Benefits: Brief
self-administered screening test. Requires professional evaluation to verify
diagnosis.
(e). Zung Questionnaire.
What it measures: Depression. Benefits: Brief self-administered screening test.
Requires professional evaluation to verify diagnosis.
(f). Diagnostic Studies. Imaging of the spine
and/or extremities is a generally accepted, well-established, and widely used
diagnostic procedure when specific indications, based on history and physical
examination, are present. Physicians should refer to individual OWCA guidelines
for specific information about specific testing procedures.
(g). Radiographic Imaging, MRI, CT, bone
scan, radiography, SPECT and other special imaging studies may provide useful
information for many musculoskeletal disorders causing chronic pain. Single
Photon Emission Computerized Tomography (SPECT): A scanning technique which may
be helpful to localize facet joint pathology and is useful in determining which
patients are likely to have a response to facet injection. SPECT combines bone
scans & CT Scans in looking for facet joint pathology.
(h). Electrodiagnostic studies may be useful
in the evaluation of patients with suspected myopathic or neuropathic disease
and may include Nerve Conduction Studies (NCS), Standard Needle
Electromyography, or Somatosensory Evoked Potential (SSEP). The evaluation of
electrical studies is difficult and should be relegated to specialists who are
well trained in the use of this diagnostic procedure.
(i). Special Testing Procedures may be
considered when attempting to confirm the current diagnosis or reveal
alternative diagnosis. In doing so, other special tests may be performed at the
discretion of the physician.
(j).
Testing for complex regional pain syndrome (CRPS-I) or sympathetically
maintained pain (SMP) is described in the Complex Regional Pain Syndrome/Reflex
Sympathetic Dystrophy Medical Treatment Guidelines.
c. While there is some
agreement about which psychological factors need to be assessed in patients
with chronic pain, a comprehensive psychological evaluation should attempt to
identify both primary psychiatric risk factors or "red flags" (e.g., psychosis,
active suicidality) as well as secondary risk factors or "yellow flags" (e.g.,
moderate depression, job dissatisfaction). Significant personality disorders
must be taken into account when considering a patient for spinal cord
stimulation and other major procedures.
d. Psychometric testing is a valuable
component of a consultation to assist the physician in making a more effective
treatment plan. There is good evidence that psychometric testing can have
significant ability to predict medical treatment outcome. For example, one
study found that psychometric testing exceeded the ability of discography to
predict disability in patients with low back pain. Pre-procedure
psychiatric/psychological evaluation must be done prior to diagnostic
confirmatory testing for a number of procedures. Examples include discography
for fusion, spinal cord stimulation, or intrathecal drug delivery systems, and
a psychologist employed by the physician planning to perform the procedure
should not do them and they should not be done by a psychologist employed by
the physician planning to perform the procedure.
e. In many instances, psychological testing
has validity comparable to that of commonly used medical tests; for example,
the correlation between high trait anger and blood pressure is equal to the
correlation between reduced blood flow and the failure of a synthetic
hemodialysis graft. Thus, psychometric testing may be of comparable validity to
medical tests and may provide unique and useful diagnostic
information.
f. All patients who
are diagnosed as having chronic pain should be referred for a psychosocial
evaluation, as well as concomitant interdisciplinary rehabilitation treatment.
This referral should be performed in a way so as to not imply that the patients
claims are invalid or that the patient is malingering or mentally ill. Even in
cases where no diagnosable mental condition is present, these evaluations can
identify social, cultural, coping, and other variables that may be influencing
the patients recovery process and may be amenable to various treatments
including behavioral therapy. As pain is understood to be a biopsychosocial
phenomenon, these evaluations should be regarded as an integral part of the
assessment of chronic pain conditions.
i.
Qualifications
(a). A psychologist with a
PhD, PsyD, or EdD credentials or a physician with Psychiatric MD/DO credentials
may perform the initial comprehensive evaluations. It is preferable that these
professionals have experience in diagnosing and treating chronic pain disorders
and/or working with patients with physical impairments.
(b). Psychometric tests should be
administered by psychologists with a PhD, PsyD, or EdD or health professionals
working under the supervision of a doctorate level psychologist. Physicians
with appropriate training may also administer such testing, but interpretation
of the tests should be done by properly credentialed mental health
professionals.
ii.
Clinical Evaluation. Special note to health care providers: most providers are
required to adhere to the federal regulations under the Health Insurance
Portability and Accountability Act (HIPAA). Unlike general health insurers,
workers compensation insurers are not required to adhere to HIPAA standards.
Thus, providers should assume that sensitive information included in a report
sent to the insurer could be forwarded to the employer. It is recommended that
the health care provider either obtain a full release from the patient
regarding information that may go to the employer or not include sensitive
health information not directly related to the work related conditions in
reports sent to the insurer.
(a). All chronic
pain patients should have a clinical evaluation that addresses the following
areas recalling that not all details should be included in the report sent to
the insurer due to the HIPAA issue noted above:
(i). history of injury-The history of the
injury should be reported in the patients words or using similar terminology.
Caution must be exercised when using translators.
[a]. nature of injury;
[b]. psychosocial circumstances of the
injury;
[c]. current symptomatic
complaints;
[d]. extent of medical
corroboration;
[e]. treatment
received and results;
[f].
adherence with treatment;
[g].
coping strategies used, including perceived locus of control, catastrophizing,
and risk aversion;
[h]. perception
of medical system and employer;
[i]. history of response to prescription
medications.
(ii).
health history
[a]. nature of
injury;
[b]. medical
history;
[c]. psychiatric history:
to include past diagnoses, counseling, medications, and response to
treatment;
[d]. history of
substance related and addictive disorders to include: alcohol, opioids,
medications (sedative, hypnotic, and anxiolytic), stimulants, prescriptions
drug abuse, nicotine use and other substances of abuse/dependence;
[e]. activities of daily living;
[f]. past, recent, and concurrent
stressors.
[g]. previous injuries,
including disability, impairment, and compensation
(iii). psychosocial history
[a]. childhood history, including
abuse/neglect;
[b]. educational
history;
[c]. family history,
including disability;
[d]. marital
history and other significant adulthood activities and events;
[e]. legal history, including but not limited
to substance use related, domestic violence, criminal and civil
litigation;
[f]. employment
history;
[g]. military duty:
Because post-traumatic stress disorder (PTSD) might be an unacceptable
condition for many military personnel to acknowledge, it may be prudent to
screen initially for signs of depression or anxiety-both of which may be
present in PTSD;
[h]. signs of
pre-injury psychological dysfunction;
[i]. financial history.
[j]. current living situation including
roommates, family, intimate partners, and financial support;
[k]. prior level of function including
self-care, community, recreational, and employment
activities.
(iv).
Psychological test results, if performed
(v). assessment of any danger posed to self
or others.
(vi). Current
psychiatric diagnosis consistent with the standards of the American Psychiatric
Association's Diagnostic and Statistical Manual of Mental Disorders.
(vii). Pre-existing psychiatric conditions.
Treatment of these conditions is appropriate when the pre-existing condition
affects recovery from chronic pain.
(viii). causality-to address medically
probable cause and effect, and to distinguish pre-existing psychological
symptoms, traits, and vulnerabilities from current symptoms.
(ix). Treatment recommendations with respect
to specific goals, frequency, timeframes, and expected outcomes.
(x). mental status exam including
orientation, cognition, activity, speech, thinking, affect, mood, and
perception. May include screening tests such as the mini mental status exam or
frontal assessment battery if appropriate.
iii. Tests of Psychological Functioning.
Psychometric Testing is a valuable component of a consultation to assist the
physician in making a more effective treatment plan. Psychometric testing is
useful in the assessment of mental conditions, pain conditions, cognitive
functioning, treatment planning, vocational planning, and evaluation of
treatment effectiveness. While there is no general agreement as to which
psychometric tests should be specifically recommended for psychological
evaluations of chronic pain conditions, standardized tests are preferred over
those which are not for assessing diagnosis. Generally, it is helpful if tests
consider the following issues: validity, physical symptoms, affective
disorders, character disorders and traits, and psychosocial history. Character
strengths that support the healing/rehabilitative process should also be
evaluated and considered with any dysfunctional behavior patterns or pathology
to more accurately assess the patients prognosis and likely response to a
proposed intervention. In contrast, non-standardized tests can be useful for
"ipsative" outcome assessment, in which a test is administered more than once
and a patients current and past reports are compared. It is appropriate for the
mental health provider to use their discretion and administer selective
psychometric tests within their expertise and within standards of care in the
community Use of screening psychometrics by non-mental health providers is
encouraged, but mental health provider consultation should always be utilized
for chronic pain patients in which invasive palliative pain procedures or
chronic opiate treatment is being contemplated. Some of these tests are
available in Spanish and other languages, and many are written at a sixth grade
reading level. Examples of frequently used psychometric tests performed
include, but not limited to, the following.
(a). Comprehensive Inventories for Medical
Patients
(i). Battery for Health Improvement,
2nd Edition (BHI-2);
(ii). Millon
Behavioral Medical Diagnostic (MBMD);
(b). Comprehensive Psychological Inventories.
(i). Millon Clinical Multiaxial
Inventory;
(ii). Minnesota
Multiphasic Personality Inventory, 2nd Edition (MMPI-2).
(iii). Personality Assessment Inventory
(PAI).
(c). Brief
Multidimensional Screens for Medical Patients. Treating providers, to assess a
variety of psychological and medical conditions, including depression, pain,
disability and others, may use brief instruments. These instruments may also be
employed as repeated measures to track progress in treatment, or as one test in
a more comprehensive evaluation. Brief instruments are valuable in that the
test may be administered in the office setting and hand scored by the
physician. Results of these tests should help providers distinguish which
patients should be referred for a specific type of comprehensive evaluation.
(i). Brief Battery for Health Improvement,
2nd Edition (BBHI-2);
(ii). Pain
Patient Profile (P-3);
(iii).
SF-36;
(iv). Sickness Impact
Profile (SIP);
(v). McGill Pain
Questionnaire (MPQ);
(vi). McGill
Pain Questionnaire-Short Form (MPQ-SF);
(vii). Oswestry Disability
Questionnaire.;
(viii). Visual
Analog Scales (VAS).;
(ix).
Numerical Rating Scale (NRS);
(x).
Chronic Pain Grade Scale (CPGS);
(xi). Pain Catastrophizing Scale
(PCS).
(d). Brief
Multidimensional Screens for Psychiatric Patients. These tests are designed for
detecting various psychiatric syndromes, but in general are more prone to false
positive findings when administered to medical patients.
(i). Brief Symptom Inventory (BSI);
(ii). Brief Symptom Inventory-18
(BSI-18);
(iii). Symptom Check List
-90 Revised (SCL 90 R).
(e). Brief Specialized Psychiatric Screening
Measures:
(i). Beck Depression Inventory
(BDI);
(ii). Center of
Epidemiologic Studies-Depression Questionnaire (CES-D);
NOTE: Designed for assessment of psychiatric patients,
not pain patients, which can bias results, and this should be a consideration
when using.
(iii). Brief
Patient Health Questionnaire from PRIME - MD. (The PHQ-9 may also be used as a
depression screen.);
(iv). Zung
Depression Questionnaire;
NOTE: The Zung Depression Scale must be distinguished
from the Modified Zung Depression scale used by the DRAM (a QPOP measure). The
Zung Depression Scale has different items and a different scoring system than
the Modified Zung Depression scale, making the cutoff scores markedly
different. The cutoff scores for one measure cannot be used for the
other.
(v). General Anxiety
Disorder 7-item scale (GAD-7).